Severe hypophosphatemia following idecabtagene vicleucel regardless of the severity of cytokine release syndrome.
Hayashino K, Kitamura W, Fujii N, Terao T, Kobayashi H, Kamoi C, Kondo T, Seike K, Fujiwara H, Asada N, Ennishi D, Fujii K, Maeda Y.
Hayashino K, et al. Among authors: maeda y.
Cytotherapy. 2025 Jan 6:S1465-3249(25)00003-9. doi: 10.1016/j.jcyt.2024.12.014. Online ahead of print.
Cytotherapy. 2025.
PMID: 39846935